间充质
胆管上皮细胞
类有机物
肝细胞
体外
生物
细胞生物学
体内
表型
肝病
肝细胞学
人肝
中胚层
功能(生物学)
细胞
病理
纤毛
骨小管
癌症研究
胆管疾病
电池类型
肝移植
肝细胞
人性化鼠标
肝星状细胞
肝再生
作者
Lei Yuan,Sagarika Dawka,Yohan Kim,Anke Liebert,Fabian Rost,Robert Arnes‐Benito,Franziska Baenke,Christina Götz,David Tsang,Andrea Schuhmann,Anna Shevchenko,Roberta Rezende de Castro,Seung-Hee Kim,Aleksandra Sljukic,Anna M. Dowbaj,Andrej Shevchenko,Daniel Seehofer,Dongho Choi,Georg Damm,Daniel E. Stange
出处
期刊:Nature
[Nature Portfolio]
日期:2025-12-17
卷期号:650 (8101): 438-449
被引量:5
标识
DOI:10.1038/s41586-025-09884-1
摘要
The development of complex multicellular human in vitro systems holds great promise for modelling disease and advancing drug discovery and tissue engineering1. In the liver, despite the identification of key signalling pathways involved in hepatic regeneration2,3, in vitro expansion of human hepatocytes directly from fresh patient tissue has not yet been achieved, limiting the possibility of modelling liver composite structures in vitro. Here we first developed human hepatocyte organoids (h-HepOrgs) from 28 different patients. Patient-derived hepatocyte organoids sustained long-term expansion of hepatocytes in vitro and maintained patient-specific gene expression and bile canaliculus features and function of the in vivo tissue. After transplantation, expanded h-HepOrgs rescued the phenotype of a mouse model of liver disease. By combining h-HepOrgs with portal mesenchyme and our previously published cholangiocyte organoids4-6, we generated patient-specific periportal liver assembloids that retain the histological arrangement, gene expression and cell interactions of periportal liver tissue, with cholangiocytes and mesenchyme embedded in the hepatocyte parenchyma. We leveraged this platform to model aspects of biliary fibrosis. Our human periportal liver assembloid system represents a novel in vitro platform to investigate human liver pathophysiology, accelerate drug development, enable early diagnosis and advance personalized medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI